DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Flourie B, Hagege H, Tucat G. et al.
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.
Aliment Pharmacol Ther 2013;
37: 767-775
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.